Aesthetic Medical International Holdings Group Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Aesthetic Medical International Holdings Group.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	20.9%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Why Investors Shouldn't Be Surprised By Aesthetic Medical International Holdings Group Limited's (NASDAQ:AIH) 27% Share Price Plunge

Feb 10

There Is A Reason Aesthetic Medical International Holdings Group Limited's (NASDAQ:AIH) Price Is Undemanding

Dec 18

Aesthetic Medical International Holdings Group Limited's (NASDAQ:AIH) Revenues Are Not Doing Enough For Some Investors

Apr 17

Aesthetic Medical International GAAP EPS of -$0.01, revenue of $50.6M

Aug 17

Aesthetic Medical International and investors enter share purchase and other agreements

Jul 20

Aesthetic Medical International GAAP EPS of -$0.01, revenue of $25.35M

Jun 29

What You Need To Know About Aesthetic Medical International Holdings Group Limited's (NASDAQ:AIH) Investor Composition

Mar 20

Aesthetic Medical International beats on revenue

Nov 30

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Aesthetic Medical International Holdings Group no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

OTCPK:PAIY.Y - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2024	727	-48	N/A	N/A	N/A
3/31/2024	715	-48	N/A	N/A	N/A
12/31/2023	683	-37	19	74	N/A
9/30/2023	665	-44	N/A	N/A	N/A
6/30/2023	651	-82	N/A	N/A	N/A
3/31/2023	658	-73	N/A	N/A	N/A
12/31/2022	670	-76	-77	-75	N/A
9/30/2022	549	-363	N/A	N/A	N/A
6/30/2022	678	-198	N/A	N/A	N/A
3/31/2022	671	-503	N/A	N/A	N/A
12/31/2021	646	-587	18	51	N/A
9/30/2021	965	-358	N/A	N/A	N/A
6/30/2021	1,078	-360	N/A	N/A	N/A
3/31/2021	946	-243	N/A	N/A	N/A
12/31/2020	902	-235	-46	-1	N/A
9/30/2020	777	-216	N/A	N/A	N/A
6/30/2020	734	-83	N/A	N/A	N/A
3/31/2020	779	35	N/A	N/A	N/A
12/31/2019	869	136	11	87	N/A
9/30/2019	844	-89	N/A	N/A	N/A
6/30/2019	798	-192	-36	38	N/A
3/31/2019	764	-242	N/A	N/A	N/A
12/31/2018	761	-255	-41	5	N/A
12/31/2017	697	-77	N/A	77	N/A
12/31/2016	585	50	N/A	52	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de PAIY.Y es superior a la tasa de ahorro (2.6%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de PAIY.Y crezcan más rápidamente que el mercado US

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de PAIY.Y crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de PAIY.Y crezcan más rápidamente que el mercado de US.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de PAIY.Y crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de PAIY.Y se prevé que sea elevada dentro de 3 años.

Aesthetic Medical International Holdings Group Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Aesthetic Medical International Holdings Group Limited Provides Revenue Guidance for the Second Quarter of 2021

Recent updates

Aesthetic Medical International Holdings Group Limited(OTCPK:PAIY.Y) dropped from NASDAQ Composite Index

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel

Aesthetic Medical International Holdings Group Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing

Full year 2023 earnings released: CN¥0.84 loss per share (vs CN¥2.79 loss in FY 2022)

Aesthetic Medical International Holdings Group Limited to Report Fiscal Year 2023 Final Results on Apr 25, 2024

New minor risk - Financial data availability

Aesthetic Medical International Holdings Announces Receipt of Letter of Expected Delisting Determination from Nasdaq Staff and Intention to Request Hearing Before the Nasdaq Hearings Panel

Why Investors Shouldn't Be Surprised By Aesthetic Medical International Holdings Group Limited's (NASDAQ:AIH) 27% Share Price Plunge

There Is A Reason Aesthetic Medical International Holdings Group Limited's (NASDAQ:AIH) Price Is Undemanding

Aesthetic Medical International Holdings Group Limited Announces Change of Director

New major risk - Share price stability

Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

New major risk - Financial position

Second quarter 2023 earnings released: CN¥0.24 loss per share (vs CN¥0.062 loss in 2Q 2022)

New major risk - Shareholder dilution

Aesthetic Medical International Holdings Group Limited Announces Board and Committee Changes

An unknown buyer entered into an agreement to acquire Shenzhen Miaoyan Medical Technology Investment Co., Ltd. from Aesthetic Medical International Holdings Group Limited (NasdaqCM:AIH) for CNY 1.9 million.

Aesthetic Medical International Holdings Group Limited to Report Q1, 2023 Results on May 17, 2023

Full year 2022 earnings released: CN¥2.79 loss per share (vs CN¥26.68 loss in FY 2021)

Aesthetic Medical International Holdings Group Limited's (NASDAQ:AIH) Revenues Are Not Doing Enough For Some Investors

Aesthetic Medical International Holdings Group Limited announced that it has received CNY 170.000002 million in funding from Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)

Aesthetic Medical International Holdings Receives a Letter of Expected Delisting Determination from Nasdaq Staff and Requests a Hearing Before the Nasdaq Hearings Panel

Third quarter 2022 earnings released: CN¥1.12 loss per share (vs CN¥7.50 loss in 3Q 2021)

Aesthetic Medical International Holdings Group Limited to Report Q3, 2022 Results on Nov 29, 2022

Less than half of directors are independent

Second quarter 2022 earnings released: CN¥0.062 loss per share (vs CN¥1.65 loss in 2Q 2021)

Aesthetic Medical International GAAP EPS of -$0.01, revenue of $50.6M

Aesthetic Medical International Holdings Group Limited to Report First Half, 2022 Results on Aug 17, 2022

Aesthetic Medical International Holdings Group Limited, Annual General Meeting, Sep 08, 2022

Less than half of directors are independent

Aesthetic Medical International Holdings Group Limited announced that it expects to receive CNY 170.000002 million in funding from Hainan Oriental Jiechuang Investment Partnership

Aesthetic Medical International and investors enter share purchase and other agreements

Aesthetic Medical International Holdings Group Limited announced that it has received CNY 99.999999 million in funding from Lafang China Co.,Ltd, Hawyu (HK) Limited

Aesthetic Medical International GAAP EPS of -$0.01, revenue of $25.35M

Aesthetic Medical International Receives Nasdaq Notice Regarding Non-Compliance with Minimum Stockholders’ Equity Requirement

Less than half of directors are independent

Aesthetic Medical International Announces Change of Board Members and Committee Composition

Second quarter 2021 earnings released: CN¥1.65 loss per share (vs CN¥2.85 loss in 2Q 2020)

First quarter 2021 earnings released: CN¥0.84 loss per share (vs CN¥3.66 loss in 1Q 2020)

Aesthetic Medical International Holdings Group Limited Provides Revenue Guidance for the Second Quarter of 2021

Aesthetic Medical International Holdings Group Limited announced that it expects to receive $15.099993 million in funding from Lafang China Co.,Ltd

Full year 2020 earnings released: EPS CN¥10.83 (vs CN¥8.87 in FY 2019)

Aesthetic Medical International Holdings Group Limited Reports Impairment of Non-Current Assets for the Fourth Quarter of 2020

What You Need To Know About Aesthetic Medical International Holdings Group Limited's (NASDAQ:AIH) Investor Composition

New 90-day high: US$9.25

New 90-day high: US$6.23

Third quarter 2020 earnings released: CN¥0.78 loss per share

Revenue beats expectations

Aesthetic Medical International beats on revenue

New 90-day high: US$6.19

Aesthetic Medical International Holdings Group Limited Announces Resignation of Fan Peng as Chief Strategy Officer

New 90-day low - US$4.23

Aesthetic Medical International Holdings Group Limited (NasdaqGM:AIH) acquired three treatment centers.

Aesthetic Medical International Holdings Group Limited (NasdaqGM:AIH) completed the acquisition of 70% stake in Xi'an New Pengai Yueji Aesthetic Medical Clinic Co., Ltd. for CNY 18 million.

New 90-day low - US$5.08

Aesthetic Medical International Holdings Group Limited (NasdaqGM:AIH) entered into a definitive agreement to acquire 51% stake in Guangdong Hanfei Investment Management Co., Ltd.

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento